Effect of henagliflozin on left ventricular mass index in dialysis patients with HFpEF (HELD-HF): protocol for a multicentre, randomised, double-blind, placebo-controlled trial

Introduction Heart failure with preserved ejection fraction (HFpEF) is a prevalent comorbidity among patients with end-stage kidney disease. Although sodium-glucose cotransporter 2 inhibitors are validated in treating heart failure and ameliorating left ventricular hypertrophy among non-dialysis pat...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Wei Wang, Ying Li, Meng Jiang, Jun Pu, Jieying Wang, Hao Yan, Wei Fang, Yan Fang, Weiming Zhang, Renhua Lu, Huihua Pang, Shang Liu, Yijun Zhou, Yinghui Qi, Zhenyuan Li, Leyi Gu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2024-08-01
Edice:	BMJ Open
On-line přístup:	https://bmjopen.bmj.com/content/14/8/e087617.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!